Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

440 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A clinical trial of biochemical modulation of 5-fluorouracil with N-phosphonoacetyl-L-aspartate and thymidine in advanced gastric and anaplastic colorectal cancer.
Windschitl HE, O'Connell MJ, Wieand HS, Krook JE, Rubin J, Moertel CG, Kugler JW, Pfeifle DM, Goldberg RM, Laurie JA. Windschitl HE, et al. Among authors: goldberg rm. Cancer. 1990 Sep 1;66(5):853-6. doi: 10.1002/1097-0142(19900901)66:5<853::aid-cncr2820660507>3.0.co;2-v. Cancer. 1990. PMID: 2201430 Clinical Trial.
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancer.
Ingle JN, Foley JF, Mailliard JA, Krook JE, Hartmann LC, Jung SH, Veeder MH, Gesme DH Jr, Hatfield AK, Goldberg RM. Ingle JN, et al. Among authors: goldberg rm. Cancer. 1994 May 1;73(9):2337-43. doi: 10.1002/1097-0142(19940501)73:9<2337::aid-cncr2820730916>3.0.co;2-q. Cancer. 1994. PMID: 8168039 Clinical Trial.
Prospectively randomized North Central Cancer Treatment Group trial of intensive-course fluorouracil combined with the l-isomer of intravenous leucovorin, oral leucovorin, or intravenous leucovorin for the treatment of advanced colorectal cancer.
Goldberg RM, Hatfield AK, Kahn M, Sargent DJ, Knost JA, O'Connell MJ, Krook JE, Maillard JA, Wiesenfeld M, Schaefer PL, Tirona MT, Moertel CG. Goldberg RM, et al. J Clin Oncol. 1997 Nov;15(11):3320-9. doi: 10.1200/JCO.1997.15.11.3320. J Clin Oncol. 1997. PMID: 9363861 Clinical Trial.
Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers.
Halling KC, French AJ, McDonnell SK, Burgart LJ, Schaid DJ, Peterson BJ, Moon-Tasson L, Mahoney MR, Sargent DJ, O'Connell MJ, Witzig TE, Farr GH Jr, Goldberg RM, Thibodeau SN. Halling KC, et al. Among authors: goldberg rm. J Natl Cancer Inst. 1999 Aug 4;91(15):1295-303. doi: 10.1093/jnci/91.15.1295. J Natl Cancer Inst. 1999. PMID: 10433618
Rapid reporting and review of an increased incidence of a known adverse event.
Sargent DJ, Goldberg RM, Mahoney MR, Hillman DW, McKeough T, Hamilton SF, Darcy JM, Anderson VL, Krook JE, O'Connell MJ. Sargent DJ, et al. Among authors: goldberg rm. J Natl Cancer Inst. 2000 Jun 21;92(12):1011-3. doi: 10.1093/jnci/92.12.1011. J Natl Cancer Inst. 2000. PMID: 10861314 No abstract available.
A three-outcome design for phase II clinical trials.
Sargent DJ, Chan V, Goldberg RM. Sargent DJ, et al. Among authors: goldberg rm. Control Clin Trials. 2001 Apr;22(2):117-25. doi: 10.1016/s0197-2456(00)00115-x. Control Clin Trials. 2001. PMID: 11306150
440 results